Strategy for Building Resilient Health Systems and Post-COVID-19 Pandemic Recovery to Sustain and Protect Public Health Gains
Loading...
Cite
Strategy for Building Resilient Health Systems and Post-COVID-19 Pandemic Recovery to Sustain and Protect Public Health Gains. (2022). [Technical reports]. PAHO. https://iris.paho.org/handle/10665.2/55858
Files
English; 34 pages
Date
2022
Document Number
PAHO/HSS/HS/COVID-19/21-0015
ISBN
eISBN
ISSN
DOI
Authors
Other Language Versions
Description
The COVID-19 pandemic has significantly impacted health, lives, and livelihoods in the Americas and has caused a social and economic crisis characterized by mass unemployment, increased impoverishment, and exacerbation of longstanding inequities. The critical path to recovery and progress toward the Sustainable Development Goals requires intensified actions to control the pandemic; adequate management of persons with COVID-19, including a) the post COVID-19 condition experienced by some individuals; the rapid and equitable deployment of COVID-19 vaccines; and the mitigation of disruptions in the provision and availability of essential health services to protect health gains. A progressive transition from pandemic response to recovery will require a renewed focus on building sustainable, resilient health systems, informed by and building on the COVID-19 response.
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item Recomendaciones para el desarrollo de sistemas de salud resilientes en las Américas(2023)[RESUMEN]. En este artículo de opinión y análisis se describen las líneas de acción estratégicas para desarrollar siste- mas de salud resilientes y al mismo tiempo promover la recuperación en la etapa posterior a la pandemia de COVID-19, a fin de mantener y proteger los logros de la salud pública. Asimismo, se presenta una contextuali- zación de los desafíos y oportunidades en la Región de las Américas, y se ofrecen recomendaciones para su implementación. Urge impulsar el desarrollo de sistemas de salud resilientes a través de la implementación de cuatro líneas de acción definidas en la Estrategia adoptada por los Estados Miembros de la Organización Panamericana de la Salud en septiembre de 2021. La transformación de los sistemas de salud debe basarse en la adopción de un modelo integral de atención primaria de la salud, un enfoque priorizado sobre las funciones esenciales de salud pública, el fortalecimiento de las redes integrales de servicios de salud, y el aumento en el financiamiento público, sobre todo para el primer nivel de atención. La implementación de estas líneas de acción no solo busca consolidar la respuesta inmediata a las crisis, sino también enmarcarla en los esfuerzos de recuperación y desarrollo sostenible de los sistemas de salud, reduciendo sus vulnerabi- lidades estructurales y así poder estar mejor preparados para responder a futuras crisis.Item Latin America and the Caribbean Regional Overview of Food Security and Nutrition 2024 – Building resilience to climate variability and extremes for food security and nutrition(PAHO, 2025-11-19)[Introduction] The 2024 edition of the Regional Overview of Food Security and Nutrition for Latin America and the Caribbean provides an update on the region’s progress towards achieving the Sustainable Development Goals (SDGs), specifically Target 2.1 (ending hunger) and Target 2.2 (eradicating all forms of malnutrition) by 2030. This year’s report focuses on the impact of climate variability and extremes, such as drought, flooding and storms on food security and nutrition. As the second-most climate-exposed region globally, Latin America and the Caribbean faces significant challenges due to rising temperatures and more frequent and severe extreme weather events. In addition, major drivers of food insecurity and malnutrition such as climate variability and extremes, conflicts, economic slowdowns and downturns, combined with well-established underlying factors, such as the lack of access to and unaffordability of healthy diets, unhealthy food environments and high and persistent inequality, have intensified. Addressing them will require the implementation of diverse portfolios of policies, investments and legislation to accelerate the transformation of agrifood systems and strengthen their resilience to the major drivers. It will require a comprehensive, intersectional, rights-based and systemic approach that considers people’s livelihoods, promotes access to and affordability of healthy diets, and strengthens resilience in agrifood systems. In this context, the report calls for transformative changes across agrifood systems, urging the integration of climate strategies, poverty alleviation efforts and inclusive economic development. Strengthening resilience is essential to prevent future setbacks in food security and nutrition, avoid worsening the nutritional situation in some countries and continue to move towards a more equitable, sustainable and food-secure future. This report highlights the urgent need for accelerated action to build resilience to the major drivers within agrifood systems to safeguard the region’s progress towards eliminating hunger, food insecurity and malnutrition while ensuring long-term sustainability.Item Acordo sobre pandemias e acesso a vacinas para países de baixa e média renda(2025-04-28)[RESUMO]. A pandemia de COVID-19 expôs falhas nos planos globais de preparação e resposta a emergências de saúde pública, destacando a urgência em garantir o acesso equitativo a tecnologias e produtos de saúde, especialmente em países de baixa e média renda (PBMR). Neste contexto, a Organização Mundial da Saúde negocia um Acordo sobre Pandemias para fortalecer a governança global, reduzir as disparidades entre países de alta renda (PAR) e PBMR e aprimorar a prevenção e resposta a futuras pandemias. Os Artigos 10 e 11 da versão mais recente da proposta de 14 de dezembro de 2024 abordam a produção diversificada e sustentável de produtos de saúde e a transferência de tecnologia e know-how, com foco nos PBMR. Estes dispositivos promovem a capacitação nacional para a produção de insumos, a transparência nos termos de licenciamento e o uso de flexibilidades do Acordo TRIPS sobre propriedade intelectual. Contudo, ainda persistem lacunas, como a ausência de definições claras para pandemias e produtos de saúde e a ênfase em medidas voluntárias. O Brasil, com tradição na produção de vacinas, tem potencial para se beneficiar do novo contexto internacional, fortalecendo sua capacidade tecnológica e aprimorando seu ecossistema de segurança sanitária. A adoção de políticas setoriais e intersetoriais, a participação em iniciativas de transferência de tecnologia e conhecimento, além do investimento na capacitação de recursos humanos são medidas estratégicas. Estas ações contribuem para a equidade no acesso a vacinas, especialmente para populações vulneráveis, em alinhamento com as diretrizes da Agenda de Imunização 2030 e as lições aprendidas na resposta à COVID-19.Item Annual Report of the Director of the Pan American Sanitary Bureau 2021. Working through the COVID‑19 Pandemic. (Official Document;364)(PAHO, 2021)The Director’s 2021 annual report on the work of the Pan American Sanitary Bureau (the Bureau), Regional Office for the Americas of the World Health Organization, highlights the technical cooperation undertaken by the Bureau during the period from July 2020 to June 2021, within the framework of the 2020–2025 Strategic Plan of the Pan American Health Organization (PAHO). The theme of the report is: Working through the COVID-19 Pandemic. The period covered has been the most challenging ever encountered by PAHO. The pandemic, through its devastating health and economic consequences, has severely impacted people’s lives and livelihoods and disrupted countries, societies, economies, and their development. This has occurred in conjunction with the inevitable challenges on the road to equitable, sustainable development and the achievement of the 2030 Sustainable Development Goals and the objectives of the Sustainable Health Agenda for the Americas 2018–2030. The publication opens with a preface by the Director of PASB, a concise executive summary, and a brief introduction. It then presents a comprehensive review of PAHO’s technical cooperation, and of the Bureau’s institutional and strengthening functions. The report highlights achievements, challenges, and lessons learned as the Bureau undertook technical cooperation with PAHO Member States at national, subregional, and regional levels within the context of the COVID-19 pandemic, working with traditional and new partners to find equitable solutions for emerging and persisting health issues in the Region of the Americas. It also looks ahead, analyzing those opportunities brought to light by the COVID-19 experience for strengthening PAHO’s promotion of and contribution to equity and progressive realization of the right to health. Moreover, it indicates how the Bureau, with the concurrence and guidance of Member States, and in collaboration with partners, will take advantage of such opportunities. This report is complemented by the Financial Report of the Director, and the Report of the External Auditor for the year 2020.Item XI Ad Hoc Meeting of the PAHO Technical Advisory Group (TAG) on Vaccine-Preventable Diseases, 21 November 2023. Virtual(PAHO, 2024)The Region of the Americas is recovering its immunization coverage rates for most antigens. In 2022, the coverage rate for the third dose of the vaccine against diphtheria, tetanus, and pertussis (DTP3) was 90% – up from 86% in 2021. Overall, 1.3 million children younger than 1 year remain unvaccinated, compared to 1.9 million in 2021. Of course, the road to recovery from the COVID-19 pandemic is long, but the Americas are showing signs of progress. However, this progress is under threat from persistent infections that cause heavy burdens of disease in the Americas. Especially heavy is the burden of dengue virus. In 2002, dengue cases exceeded 1 million, whereas more than 2 million were recorded in 2013, and more than 3 million in 2019. While the regional dengue case fatality rate remains below 0.05%, the increased transmission is undermining countries’ efforts for social and economic recovery. In September 2023, the World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization recommended the use of the two-dose TAK-003 dengue vaccine series produced by Takeda for children ages 6 to 16 years who live in settings with high dengue disease burden and high transmission intensity. During this XI Technical Advisory Group (TAG) meeting, the Pan American Health Organization (PAHO) Secretariat asked TAG members to consider the evidence on the safety and effectiveness of this vaccine and propose recommendations for its use in the Americas. Also, respiratory syncytial virus (RSV) is cause for great concern in the Americas. Data reported from Member States to the PAHO integrated respiratory surveillance network SARInet Plus indicate that RSV contributes significantly to the burden of respiratory diseases in the Region. By age group, RSV-associated cases and hospitalizations have been primarily reported among infants younger than 2 years. In recent months, both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) approved the RSVpreF vaccine Abrysvo produced by Pfizer for pregnant women, with the goal of reducing RSV incidence among newborns younger than 6 months. Again, TAG members were called to provide their recommendations to PAHO on the use of this vaccine in the Americas.